Chemicals
The companies featured on PressReleaseFinder are active in several industries.
19 Nov 2025
Syensqo wins SPE Innovation Awards 2025 for "Most innovative use of plastics"
Syensqo, a global leader in high-performance polymers, proudly announces that it has won the Materials Category at the 2025 Society of Plastics Engineers (SPE) Innovation Awards.
14 Nov 2025
Archroma awarded EcoVadis Gold rating for second consecutive year
Archroma, a global leader in specialty chemicals towards sustainable solutions, has been awarded a Gold rating by EcoVadis for the second consecutive year. This places Archroma in the top 5% of more than 150,000 companies assessed globally across 150 countries and 250 industries.
Syensqo’s high-performance, medical-grade KetaSpire® PEEK has enabled the development of a new generation of orthopedic surgical guides made from the advanced polymer. Through a collaboration between Hanisch Medical and TechImport, two leading Brazilian health technology companies, these new guides provide surgeons with a lighter and more radiotransparent alternative to traditional metal instruments.
SONGWON Industrial Group today released its financial results for the 3rd quarter of 2025. During Q3/2025, the Group achieved consolidated sales of 258,616 million KRW, marking a -9.5% decline in revenue over sales recorded in the same quarter of the previous year of 285,779 million KRW. SONGWON reported a gross profit margin of 13.6% (Q3/2024: 17.6%) and a net profit of 1,697 million KRW.
Syensqo will present its range of nature- and science-inspired ingredients at Food Ingredients Europe 2025, showcasing solutions that enhance flavor, freshness and consumer trust in food, beverages and pet nutrition. These innovations help manufacturers deliver great taste with reliable flavors and preservation solutions, meeting growing demand for more natural ingredients and tastier products.
Syensqo today announced that its Eviva® Polysulfone (PSU) has been selected by BIOTRONIK, a global leader in medical technology, for use in the header of its latest Amvia Sky pacemaker models. Eviva® PSU was chosen thanks to its outstanding biocompatibility, enabling indefinite implantation inside the human body, and its exceptional transparency, which supports precise electrode placement during surgical implantation.